The Incidence and Incubation Period of False Positive Cultures in Shoulder Surgery
1 other identifier
observational
100
0 countries
N/A
Brief Summary
This study will describe the time point at which a positive culture from a patient who has undergone shoulder surgery should be treated as an infection versus a false positive result that should be disregarded. Intraoperative biopsies will be taken and cultured from 50 subjects who have undergone an "open" surgical procedure and 50 from subjects undergoing an arthroscopic procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2015
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2015
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedFirst Posted
Study publicly available on registry
November 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2018
CompletedAugust 16, 2018
August 1, 2018
2.8 years
April 25, 2015
August 14, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of positive cultures
28 days
Secondary Outcomes (1)
Incubation time clarification for culture growth if it occurs
Less than or equal to 28 days
Study Arms (2)
Open Shoulder Surgery
Culture
Arthroscopic Shoulder Surgery
Culture
Interventions
Specimens will be obtained and sent to the lab for cultures.
Eligibility Criteria
Patients with mechanical problems associated with their shoulder who elect to undergo shoulder surgery
You may qualify if:
- Patients undergoing primary open and arthroscopic shoulder surgery in which there is a clear diagnosis of a mechanical problem that is felt to be amenable to surgical intervention and there is no suspicion of infection. Examples include, but are not limited to: rotator cuff tear, labral tear, instability, impingement, and osteoarthritis.
You may not qualify if:
- Prior shoulder surgery
- Prior glenohumeral injection within the last 6 months
- Systemic or shoulder inflammatory disorder
- Any clinical, imaging, or laboratory findings that raise suspicion of infection
- Minors
- Erythrocyte sedimentation rate (ESR) \>15 mm/hr for males less than 50 years old, \>20 mm/hr for males greater than 50 years old and females less than 50 years old, and \>30 mm/hr for females greater than 50 years old
- C reactive protein (CRP) \>1 mg/d,
- Procalcitonin (PCT) \>0.05 ng/ml.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Butler-Wu SM, Burns EM, Pottinger PS, Magaret AS, Rakeman JL, Matsen FA 3rd, Cookson BT. Optimization of periprosthetic culture for diagnosis of Propionibacterium acnes prosthetic joint infection. J Clin Microbiol. 2011 Jul;49(7):2490-5. doi: 10.1128/JCM.00450-11. Epub 2011 May 4.
PMID: 21543562BACKGROUNDLevy O, Iyer S, Atoun E, Peter N, Hous N, Cash D, Musa F, Narvani AA. Propionibacterium acnes: an underestimated etiology in the pathogenesis of osteoarthritis? J Shoulder Elbow Surg. 2013 Apr;22(4):505-11. doi: 10.1016/j.jse.2012.07.007. Epub 2012 Sep 13.
PMID: 22981447BACKGROUND
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary Misamore, MD
Forte Sports Medicine and Orthopedics
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopedic Surgeon
Study Record Dates
First Submitted
April 25, 2015
First Posted
November 11, 2015
Study Start
May 1, 2015
Primary Completion
March 1, 2018
Study Completion
March 1, 2018
Last Updated
August 16, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will share